Associations between type of treatment and illness-specific locus of control in type 1 diabetes patients

Abstract

This study examined differences in diabetes-specific locus of control beliefs of 112 insulin-treated Type 1 diabetes patients undergoing either conventional therapy (CT). intensified conventional therapy (ICT) or continuous subcutaneous insulin infusion (CSII). Compared to CT with its adherence to a strici regimen, ICT and CSII allow a much greater flexibility in riming of meal5 and daily activities. On the other hand, such flexibility requires a much more active role of the patient. The hypotheses of higher internality and lower powerful others locus of control beliefs in ICT and CSll patients than in CT patients could be supported for powerful others locus of control only. A one-year follow-up replicated this finding. Furthermore, high powerful others locus of control was associated with low diabetes-related knowledge and poor glycaemic control. The relevance o f the patients' experience with the respective treatment is examined in view of the results and implications for studies on the feasibility of diabctcs regimens are discussed.

Locus of Control and Cognition in Older Adults With Type 1 Diabetes

“…19 One suggested mechanism between the relationship with dLOC and cognition is a relationship between dLOC and treatment adherence, treatment type, or metabolic control, though results are sometimes contradictory. 20,21 Health locus of control was associated with improved adherence to diabetes regimens among Iranian adults with type 1 or type 2 diabetes. 22 while a recent meta-analysis found no relationship between locus of control and metabolic control of diabetes.…”

Locus of Control and Metabolic Control of Diabetes

“…8 Conversely, others found a positive relationship between external locus of control and diabetes management. [9][10][11][12] Still others found no significant relationship between the 2 variables. The purpose of this meta-analysis is to determine if locus of control correlates with metabolic control of diabetes.…”